RE: JPM conf.8 Jan 2026 18:18
First confirmation Avacta would attend on 6th Jan via X.com
"We’re excited to join the biotech community in San Francisco with the JP Morgan Healthcare Conference & Bio Showcase 2026 happening next week. We look forward to seeing you there."
Herewith hopefully some clarification -
Verbatim from Grok:
Q Is Avacta due to make a presentation there.
A The main J.P. Morgan Healthcare Conference features invitation-only presentations, primarily by larger companies (e.g., Amgen, Novartis, Viking Therapeutics, and others announced timed slots with webcasts in early January 2026).
Avacta's post mentions joining the broader "biotech community" and references the parallel Bio Showcase (a partnering event), indicating attendance for meetings rather than a main-stage presentation.
No evidence of a scheduled company presentation for Avacta was identified in conference previews, attendee lists, or announcements.
Q Expand on Avacta's reference to the Bio Showcase (a partnering event).
A Expansion on Avacta's reference to the Bio Showcase:
Avacta's mention of the "Bio Showcase" in their announcement almost certainly refers to the Biotech Showcase, a prominent investor and partnering conference that runs concurrently with the J.P. Morgan Healthcare Conference during "JPM Week" in San Francisco.
Held from January 12–14, 2026, at the Hilton San Francisco Union Square, the Biotech Showcase is co-produced by Demy-Colton and EBD Group and focuses on connecting emerging biotech companies—like Avacta—with investors, biopharma executives, and potential partners.
Unlike the invitation-only main J.P. Morgan presentations, which cater to established players, the Biotech Showcase is tailored for private, micro-, and mid-cap biotechs.
It features over 340 presenting companies delivering pitches, one-on-one meetings facilitated through a partnering platform, panel discussions, and networking sessions.
The event attracts more than 1,200 investors managing over $400 billion in capital, emphasizing deal-making, funding opportunities, and strategic alliances in the life sciences sector.
By referencing both events together, Avacta signals its participation in the broader ecosystem of JPM Week activities, where thousands of biotech professionals converge for informal meetings and collaborations.
While no specific details confirm Avacta as a presenting company at the Biotech Showcase (public lists focus on general attendance and high-level profiles rather than exhaustive rosters at this stage), their announcement suggests a focus on leveraging the partnering aspects to advance discussions around their pre|CISION platform and oncology pipeline.
This aligns with the event's 18-year history of fostering innovation and capital access for companies in Avacta's growth stage.
+++
Overtime on the horizon for SB and Co.
Sign In
Follow the stocks
